<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="15213">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02908828</url>
  </required_header>
  <id_info>
    <org_study_id>2015/2303</org_study_id>
    <nct_id>NCT02908828</nct_id>
  </id_info>
  <brief_title>Calanus Oil Supplementation and Maximal Oxygen Uptake</brief_title>
  <official_title>Effect of Copepod Oil Supplementation (Calanus Finmarchicus) on Endurance and VO2max in Healthy Obese Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Tromso</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Calanus AS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Copepod oil is extracted from the marine copepod Calanus finmarchicus, the dominant plankton
      species in the marine food web in the Norwegian Sea. Copepods constitute the largest
      renewable and harvestable resource in the Norwegian Sea and adjacent waters, and it is now
      developed knowledge and technology for sustainable harvesting of this &quot;new&quot; resource. The
      purpose of this study is to investigate whether Calanus copepod oil supplementation has an
      equivalent effect on maximal oxygen uptake in humans to that seen in experimental studies in
      mice.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>maximal oxygen uptake (VO2max)</measure>
    <time_frame>6 months</time_frame>
    <description>Measured with indirect calorimetry at a treadmill (running/walking) with gradually increasing work load until exhaustion. After 10-15 min with warmup at 70% of maximal heart rate, work load will be increased every 1-2 minute and the changes maximal oxygen uptake (VO2) will be recorded automatically.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body composition (InBody, Japan)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported physical activity</measure>
    <time_frame>6 months</time_frame>
    <description>assessed with International Physical Activity Questionnaire (IPAQ) short version</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Calanus oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 capsules of 500 mg Calanus oil once every day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>4 capsules of 500 mg dietary oil once every day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Calanus oil</intervention_name>
    <arm_group_label>Calanus oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo dietary oil</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  in good health

          -  Body mass index (BMI) between 18,5 and 29,9

        Exclusion Criteria:

          -  Medical condition limiting VO2max (COPD or asthma).

          -  diagnosed coronary artery disease

          -  Any other significant medical condition

          -  medication effecting exercise capacity (e.i. betablockers)

          -  Pregnancy

          -  Participation in other clinical trials

          -  Shellfish allergies

          -  Systolic blood pressure &gt; 170 mmHG, or diastolic BP &gt; 105 mmHG.

          -  contraindications for maximal exercise testing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulrik Wisløff, phd prof</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Trine Karlsen, phd</last_name>
    <email>trine.karlsen@ntnu.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ulrik Wisløff, phd prof</last_name>
    <email>ulrik.wisloff@ntnu.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institutt for Medisinsk Biologi, UiT Norges arktiske universitet</name>
      <address>
        <city>Tromsø</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Terje Larsen</last_name>
      <phone>0047 776 44694</phone>
      <email>terje.larsen@uit.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>KG Jebsen-senter for Hjertetrening, NTNU</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucas Tauschek</last_name>
      <phone>0047 46430412</phone>
      <email>lucas.tauschek@ntnu.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <reference>
    <citation>Rangul V, Holmen TL, Kurtze N, Cuypers K, Midthjell K. Reliability and validity of two frequently used self-administered physical activity questionnaires in adolescents. BMC Med Res Methodol. 2008 Jul 15;8:47. doi: 10.1186/1471-2288-8-47.</citation>
    <PMID>18627632</PMID>
  </reference>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 23, 2016</lastchanged_date>
  <firstreceived_date>September 14, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Biological Products/therapeutic use</keyword>
  <keyword>Copepoda</keyword>
  <keyword>Dietary Supplements</keyword>
  <keyword>Fish Oils</keyword>
  <keyword>Fatty Acids, Omega-3</keyword>
  <keyword>Oxygen Consumption</keyword>
  <keyword>Calanus</keyword>
  <keyword>Maximal oxygen uptake</keyword>
  <keyword>Zooplankton</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
